HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $354,000 | -99.9% | 22,000 | 0.0% | 1.97% | +20.6% |
Q4 2018 | $321,860,000 | +80365.0% | 22,000 | 0.0% | 1.63% | -6.0% |
Q3 2018 | $400,000 | +7.8% | 22,000 | 0.0% | 1.74% | -27.3% |
Q2 2018 | $371,000 | -13.9% | 22,000 | 0.0% | 2.39% | +18.5% |
Q1 2018 | $431,000 | -3.4% | 22,000 | 0.0% | 2.02% | +7.2% |
Q4 2017 | $446,000 | +16.8% | 22,000 | 0.0% | 1.88% | +20.7% |
Q3 2017 | $382,000 | +35.5% | 22,000 | 0.0% | 1.56% | +15.5% |
Q2 2017 | $282,000 | -1.1% | 22,000 | 0.0% | 1.35% | -2.0% |
Q1 2017 | $285,000 | +31.3% | 22,000 | 0.0% | 1.38% | +56.3% |
Q4 2016 | $217,000 | -18.4% | 22,000 | 0.0% | 0.88% | -10.4% |
Q3 2016 | $266,000 | +40.0% | 22,000 | 0.0% | 0.98% | +36.4% |
Q2 2016 | $190,000 | -8.7% | 22,000 | 0.0% | 0.72% | -32.0% |
Q1 2016 | $208,000 | -45.4% | 22,000 | 0.0% | 1.06% | -82.4% |
Q4 2015 | $381,000 | +29.2% | 22,000 | 0.0% | 6.04% | +271.2% |
Q3 2015 | $295,000 | +8.9% | 22,000 | +83.3% | 1.63% | +78.1% |
Q2 2015 | $271,000 | +58.5% | 12,000 | 0.0% | 0.91% | +75.4% |
Q1 2015 | $171,000 | +47.4% | 12,000 | 0.0% | 0.52% | +727.0% |
Q4 2014 | $116,000 | – | 12,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |